SEP 8, 2026 · JOURNAL ARTICLE
Adjuvant therapy in glucagon-like peptide-1 receptor agonist treatment: Enhancement of efficacy and mitigation of adverse events. A review
Consilium Medicum
A narrative review proposing a multifaceted adjuvant therapy algorithm to mitigate GLP-1 agonist adverse events; lacks primary trial evidence and explicitly calls for RCT validation.
Reported
Psyllium dose10–15 g/day
Ursodeoxycholic acid dose10–15 mg/kg per day
Weight loss threshold for ursodeo…1 kg per week